3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
6
Solitary Fibrous Tumors
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Recurrent High Grade Meningioma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangioendothelioma
1
Chondrosarcoma, Mesenchymal
1
Interventions
selinexor
1
repotrectinib
1
pembrolizumab
1
pazopanib
1
Trabectedin
1
Suspensions
1
Proton Therapy
1
Magnetic Resonance Spectroscopy
1
Ifosfamide
1
Histamine H2 Antagonists
1
Fluorodeoxyglucose F18
1
Famotidine
1
FAPI-46
1
Doxorubicin
1
Capsules
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Solitary Fibrous Tumors
×
Trabectedin
×
1 year
×
Clear all
NCT04008238
2026-03-06
PIPER
Institut Bergonié
Phase NA
Completed
29 enrolled